argenx (ARGX) News Today → $21,000 in profits in six weeks? (From InvestorPlace) (Ad) Free ARGX Stock Alerts $386.08 -12.73 (-3.19%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineArgenx SE Q1 2024 Earnings Previewmsn.com - May 8 at 5:57 PMargenx SE: argenx announces results of Annual General Meeting of Shareholdersfinanznachrichten.de - May 8 at 9:07 AMargenx (ARGX) to Release Quarterly Earnings on Thursdayamericanbankingnews.com - May 8 at 5:06 AMargenx announces results of Annual General Meeting of Shareholdersglobenewswire.com - May 7 at 5:30 PMargenx to Present at BofA Securities 2024 Health Care Conferenceglobenewswire.com - May 7 at 1:00 AMRussell Investments Group Ltd. Buys 3,493 Shares of argenx SE (NASDAQ:ARGX)marketbeat.com - May 6 at 5:21 AMargenx (ARGX) to Release Earnings on Thursdaymarketbeat.com - May 2 at 10:39 AMVan ECK Associates Corp Acquires 4,973 Shares of argenx SE (NASDAQ:ARGX)marketbeat.com - May 2 at 6:40 AMargenx to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024globenewswire.com - May 2 at 1:00 AMAnnexon (ANNX) to Report Q1 Earnings: What's in the Cards?finance.yahoo.com - May 1 at 1:03 PMBiogen's Revenue Dip Meets Cost Cuts In Q1 (Rating Upgrade)seekingalpha.com - April 29 at 11:13 AMShort Interest in argenx SE (NASDAQ:ARGX) Expands By 10.8%marketbeat.com - April 29 at 7:34 AMargenx SE (NASDAQ:ARGX) Shares Purchased by New York State Common Retirement Fundmarketbeat.com - April 24 at 8:44 AMJennison Associates LLC Sells 1,243,537 Shares of argenx SE (NASDAQ:ARGX)marketbeat.com - April 23 at 8:30 AMQ1 2024 EPS Estimates for argenx SE Lifted by William Blair (NASDAQ:ARGX)marketbeat.com - April 19 at 8:18 AMFederated Hermes Inc. Raises Holdings in argenx SE (NASDAQ:ARGX)marketbeat.com - April 18 at 12:22 PMargenx's (ARGX) Outperform Rating Reiterated at Wedbushmarketbeat.com - April 18 at 10:28 AMThe Analyst Verdict: argenx In The Eyes Of 12 Expertsmarkets.businessinsider.com - April 18 at 10:27 AMargenx (NASDAQ:ARGX) Shares Gap Down to $376.26marketbeat.com - April 16 at 11:56 AMargenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Diseaseglobenewswire.com - April 16 at 1:00 AMAllspring Global Investments Holdings LLC Purchases 15,431 Shares of argenx SE (NASDAQ:ARGX)marketbeat.com - April 13 at 6:30 AMCartesian Therapeutics' Rare Disease Candidate Shows Long Lasting Benefit Over Argenx's Vyvgart, Analyst Initiates With Buymarkets.businessinsider.com - April 10 at 3:27 PMargenx SE (NASDAQ:ARGX) Position Boosted by Raymond James Financial Services Advisors Inc.marketbeat.com - April 5 at 4:17 AMChina Universal Asset Management Co. Ltd. Has $1.42 Million Holdings in argenx SE (NASDAQ:ARGX)marketbeat.com - April 4 at 6:54 PMGuru Fundamental Report for ARGXnasdaq.com - March 30 at 4:19 PMBuy Rating Affirmed for Argenx Se on Efgartigimod Progress and Regulatory Successmarkets.businessinsider.com - March 29 at 9:45 AMHere's Why argenx SE (ARGX) Pulled Back 23% in Q4msn.com - March 29 at 9:45 AMHere’s Why argenx SE (ARGX) Pulled Back 23% in Q4finance.yahoo.com - March 29 at 9:45 AMargenx SE (NASDAQ:ARGX) to Post Q3 2024 Earnings of ($1.01) Per Share, Wedbush Forecastsmarketbeat.com - March 28 at 8:44 AMBuy Rating Affirmed for Argenx Se on Strong Pipeline and Market Potentialmarkets.businessinsider.com - March 27 at 3:40 PMargenx's (ARGX) Buy Rating Reaffirmed at HC Wainwrightmarketbeat.com - March 27 at 10:59 AMReaffirming Buy Rating for Argenx with New Price Objective Following Vyvgart’s Approval in Japanmarkets.businessinsider.com - March 27 at 10:39 AMKey Takeaways From argenx Analyst Ratingsmarkets.businessinsider.com - March 27 at 10:39 AMargenx Advances Clinical Development of Efgartigimod in Primary Sjogren’s Diseasefinance.yahoo.com - March 27 at 10:39 AMWedbush Equities Analysts Increase Earnings Estimates for argenx SE (NASDAQ:ARGX)marketbeat.com - March 27 at 6:34 AMargenx Advances Clinical Development of Efgartigimod in Primary Sjogren's Diseaseglobenewswire.com - March 27 at 2:00 AMargenx Announces Annual General Meeting of Shareholders on May 7, 2024globenewswire.com - March 26 at 4:00 PMAssenagon Asset Management S.A. Has $48.88 Million Stock Position in argenx SE (NASDAQ:ARGX)marketbeat.com - March 26 at 1:56 PMScotiabank Raises argenx (NASDAQ:ARGX) Price Target to $408.00marketbeat.com - March 26 at 8:26 AMargenx SE: argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopeniafinanznachrichten.de - March 26 at 5:42 AMargenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopeniaglobenewswire.com - March 26 at 2:00 AMBuy Rating Affirmed for Argenx Following Competitive Drug Trial Failure and Promising Market Prospects for Vyvgartmarkets.businessinsider.com - March 25 at 3:36 AMargenx (NASDAQ:ARGX) Stock Rating Reaffirmed by JMP Securitiesmarketbeat.com - March 22 at 2:10 PMBuy Rating for Argenx Se Amid VYVGART’s Market Dominance and Revenue Growth Forecastmarkets.businessinsider.com - March 21 at 11:24 PMargenx (NASDAQ:ARGX) Shares Gap Up to $356.95marketbeat.com - March 21 at 3:14 PMArgenx gains after setback to Roche/Chugai myasthenia gravis therapymsn.com - March 21 at 7:36 AMReasons to Invest in argenx (ARGX)finance.yahoo.com - March 19 at 12:04 PMargenx NV ADR (ARGX)investing.com - March 19 at 7:04 AMWellington Management Group LLP Reduces Stock Position in argenx SE (NASDAQ:ARGX)marketbeat.com - March 18 at 4:53 AMAnalysts’ Top Healthcare Picks: Argenx Se (ARGX), MoonLake Immunotherapeutics (MLTX)markets.businessinsider.com - March 15 at 7:43 AM Get argenx News Delivered to You Automatically Sign up to receive the latest news and ratings for ARGX and its competitors with MarketBeat's FREE daily newsletter. Email Address READ THIS – If You Missed Out On The AI Boom (Ad)Adam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.” Click on Adam's shiny forehead for more details. ARGX Media Mentions By Week ARGX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARGX News Sentiment▼0.430.36▲Average Medical News Sentiment ARGX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARGX Articles This Week▼86▲ARGX Articles Average Week Get argenx News Delivered to You Automatically Sign up to receive the latest news and ratings for ARGX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BNTX News NBIX News BIIB News TECH News QGEN News RGEN News EXEL News PCVX News RVMD News MRNA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARGX) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding argenx SE Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.